Innovation
Best Device Concepts and Technological Trends Learning Series
Innovation in Aortic Valve Treatment
Advertisement
Episodes
Is Aortic Regurgitation the Next Major TAVR Target?
19 min.
The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities
6 min.
The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities
17 min.
The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities
16 min.
Aortic Valve Replacement Versus Clinical Surveillance in Moderate Aortic Stenosis With Reduced Ejection Fraction: Meta-Analysis of Reconstructed Time-to-Event Data
13 min.
Report of an IDE Pivotal Study of a Dedicated Leaflet Splitting Device During TAVR (SHORTCUT)
14 min.
Transcatheter Aortic Valve Repair for Aortic Insufficiency Using the Cusper Device (Cuspa)
8 min.
Innovation With a Novel Polymer Heart Valve (TRIA) Portfolio (FOLDAX)
13 min.
A Cutting-Edge Polyphenol-Based Coating Technology for the Third Generation of Polymer Heart Valves (BCI Technology)
8 min.
First-in-Human Experience With the EnCompass F2 Filter, a Novel Cerebral Embolic Protection Device for TAVR
12 min.
Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States
14 min.
Next Generation Decision Support With AI-Based Predictive Modeling for Improved Long Term Outcomes (DASI Simulations)
8 min.
Biomimetic Design Restores Flow and Hemodynamics and Leads to Significant LV Mass Regression: Update From the First-In-Human (FIH) Study With the Novel DurAVR Transcatheter Heart Valve
12 min.
New Design Features and Changing Clinical Topics for TAVR in the Next Decade!
13 min.
Valve Fracturing During Surgical Valve-in-Valve Procedures
19 min.
Access Disparities Affecting Appropriate AS Therapy
11 min.
Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program
6 min.
Dedicated TAVR Systems for AR - Technology and Program Updates: J-Valve
13 min.
The Trilogy TAVR System (JenaValve) and an Update on the ALIGN-AR Study
12 min.
SIEGEL TAVR: A Revolutionary Ultra-Low Profile Aortic Valve Based Upon Rhenium Superalloys (Mirus)
11 min.
Feasibility Study of a New Short, Self-Expanding TAVR Valve: Optimum TAV
11 min.
DurAVR: Impact of Biomimetic Design on Restoration of Hemodynamics in Early ViV Experience
11 min.
Is Leaflet Modification Sufficient to Prevent Coronary Obstruction - When to Consider Snorkel Stenting
16 min.
Can TAV-in-TAV Simulations be Useful in Procedural Planning?
11 min.
The 2024 'Toolbox' for Leaflet Modification in TAVR
6 min.
BASILICA or ShortCut for TAV-in-SAVR or TAV-in-TAV
5 min.
TELLTALE for TAV-in-SAV or TAV-in-Native
5 min.
Leaflet Modification for TAV-in-TAV
5 min.
Unsuccessful or Complicated Leaflet Modification in TAVR
19 min.
Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning
15 min.
Innovation in TAVR for Pure AR (J Valve)
13 min.
Aortic Stenosis - Lessons Learned in Highly Calcific Disease and Bicuspid Valves
11 min.
New Structural Innovation: What Is Next in the Pipeline From China
11 min.
Lifetime management of aortic stenosis
4 min.
The Lifetime Management of Aortic Stenosis: The Unmet Needs
49 min.
The Lifetime Management of Aortic Stenosis: A Heart Team Perspective
8 min.